Cargando…
DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma
The TP63 gene encodes two major protein variants; TAp63 contains a p53-like transcription domain and consequently has tumor suppressor activities whereas ΔNp63 lacks this domain and acts as an oncogene. The two variants show distinct expression patterns in normal tissues and tumors, with lymphocytes...
Autores principales: | Pokorna, Zuzana, Hrabal, Vaclav, Tichy, Vlastimil, Vojtesek, Borivoj, Coates, Philip J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331744/ https://www.ncbi.nlm.nih.gov/pubmed/35912167 http://dx.doi.org/10.3389/fonc.2022.924354 |
Ejemplares similares
-
Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma
por: Pokorna, Zuzana, et al.
Publicado: (2022) -
ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells
por: Nekulova, Marta, et al.
Publicado: (2016) -
ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019) -
Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019) -
Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation
por: Wu, H Helena, et al.
Publicado: (2021)